Citi Pharma Limited (PSX:CPHL)
63.42
-0.13 (-0.20%)
At close: Nov 13, 2026
| Market Cap | 14.49B -21.8% |
| Revenue (ttm) | 14.22B +6.9% |
| Net Income | 835.44M -6.6% |
| EPS | 3.66 -6.6% |
| Shares Out | 228.46M |
| PE Ratio | 17.34 |
| Forward PE | n/a |
| Dividend | 3.50 (5.52%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 264,764 |
| Open | 63.58 |
| Previous Close | 63.55 |
| Day's Range | 62.50 - 64.00 |
| 52-Week Range | 56.11 - 93.99 |
| Beta | 0.45 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Feb 26, 2027 |